Related content

Recent Pharmacoproteomics Studies of Warfarin in the Asia-Pacific: A New Strategy for Personalized Medicine?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 4, 2012-12 ,pp. : 322-331

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 3, 2011-09 ,pp. : 159-167

Bentham Science Publishers

Access to resources Recommend Favorite

The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine

By  

Current Drug Metabolism, Vol. 12, Iss. 5, 2011-06 ,pp. : 460-486

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Statistical Random-Effects Linear Models in Personalized Medicine

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 22-32

Bentham Science Publishers

Access to resources Recommend Favorite

Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 106-123

Bentham Science Publishers

Access to resources Recommend Favorite